Nos tutelles

CNRS UCA

Nos partenaires

FRE Recherches en Environnement FEDER

Rechercher




Accueil > Français > Équipes > Epidémiologie et Physiopathologie des Infections à Entérovirus (EPIE) > Publications

2015

par Genevieve B - publié le

HASSEL C, MIRAND A, LUKASHEV A, TERLETSKAIALADWIG E, FARKAS A, SCHUFFENECKER I, DIEDRICH S, HUEMER HP, ARCHIMBAUD C, PEIGUE-LAFEUILLE H, HENQUELL C, BAILLY JL. Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. Euro Surveill. 2015. 20(34):30005. doi : 10.2807/1560-7917.ES.2015.20.34.30005. PubMed PMID : 26530407.

POELMAN R, SCHUFFENECKER I, VAN LEER-BUTER C, JOSSET L, NIESTERS HG, LINA B ; ESCV-ECDC EV-D68 STUDY GROUP. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. J Clin Virol. 2015. 71:1-9. doi : 10.1016/j.jcv.2015.07.296. PubMed PMID : 26364237.

MIRAND A, MOLET L, HASSEL C, PEIGUE-LAFEUILLE HC, ROZENBERG F, BAILLY JL, HENQUELL C. Enterovirus A71 subgenotype B5, France, 2013. Emerg Infect Dis. 2015. 21(4):707-9. doi : 10.3201/eid2104.141093. PubMed PMID : 25811300 ; PubMed Central PMCID : PMC4378463.

VOLLE R, ARCHIMBAUD C, COURAUD PO, ROMERO IA, WEKSLER B, MIRAND A, PEREIRA B, HENQUELL C, PEIGUE-LAFEUILLE H, BAILLY JL. Differential permissivity of human cerebrovascular endothelial cells to enterovirus infection and specificities of serotype EV-A71 in crossing an in vitro model of the human blood-brain barrier. J Gen Virol. 2015. 96(Pt 7):1682-95. doi : 10.1099/vir.0.000103. PubMed PMID : 25711966.

BREBION A, MIRAND A, REGAGNON C, ARCHIMBAUD C, CHAMBON M, PEIGUE-LAFEUILLE H, HENQUELL C. Evaluation of real-time RT-PCR Rhino&EV/Cc r-gene(®) (bioMérieux) kit versions 1 and 2 for rhinovirus detection. J Clin Virol. 2015. 62:110-3. doi : 10.1016/j.jcv.2014.10.019. PubMed PMID : 25434700.

OTHMAN I, MIRAND A, SLAMA I, MASTOURI M, PEIGUE-LAFEUILLE H, AOUNI M, BAILLY JL. Enterovirus Migration Patterns between France and Tunisia. PLoS One. 2015. 10(12):e0145674. doi : 10.1371/journal.pone.0145674. PubMed PMID : 26709514 ; PubMed Central PMCID : PMC4692522.

EL HOUMAMI N, MIRAND A, DUBOURG G, HUNG D, MINODIER P, JOUVE JL, CHARREL R, RAOULT D, FOURNIER PE. Hand, foot and mouth disease and Kingella kingae infections. Pediatr Infect Dis J. 2015. 34(5):547-8. doi:10.1097/INF.0000000000000607. PubMed PMID : 25876094.

MIRAND A, PEIGUE-LAFEUILLE H. Acute flaccid myelitis and enteroviruses : an ongoing story. Lancet. 2015. 385(9978):1601-2. doi : 10.1016/S0140-6736(15)60121-0. PubMed PMID : 25638661.

SOLIS M, MEDDEB M, SUEUR C, DOMINGO-CALAP P, SOULIER E, CHABAUD A, PERRIN P, MOULIN B, BAHRAM S, STOLL-KELLER F, CAILLARD S, BARTH H, FAFI-KREMER S ; FRENCH BKV STUDY GROUP. Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement. J Clin Microbiol. 2015. 53(12):3842-52. doi : 10.1128/JCM.02145-15. PubMed PMID : 26468499 ; PubMed Central PMCID : PMC4652096.

LE GUILLOU-GUILLEMETTE H, DUCANCELLE A, BERTRAIS S, LEMAIRE C, PIVERT A, VEILLON P, BOUTHRY E, ALAIN S, THIBAULT V, ABRAVANEL F, ROSENBERG AR, HENQUELL C, ANDRÉ-GARNIER E, PETSARIS O, VALLET S, BOUR JB, BAAZIA Y, TRIMOULET P, ANDRÉ P, GAUDY-GRAFFIN C, BETTINGER D, LARRAT S, SIGNORI-SCHMUCK A, SAOUDIN H, POZZETTO B, LAGATHU G, MINJOLLE-CHA S, STOLL-KELLER F, PAWLOTSKY JM, IZOPET J, PAYAN C, LUNEL-FABIANI F. Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients. J Clin Virol. 2015. 69:203-9. doi : 10.1016/j.jcv.2015.06.096. PubMed PMID : 26209408.

RODRIGUEZ C, SOULIÉ C, MARCELIN AG, CALVEZ V, DESCAMPS D, CHARPENTIER C, FLANDRE P, RECORDON-PINSON P, BELLECAVE P, PAWLOTSKY JM, MASQUELIER B ; ANRS AC11 STUDY GROUP. HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc. PLoS One. 2015. 10(6):e0127816. doi : 10.1371/journal.pone.0127816. PubMed PMID : 26068869 ; PubMed Central PMCID : PMC4466260.

LARRAT S, VALLET S, DAVID-TCHOUDA S, CAPOROSSI A, MARGIER J, RAMIÈRE C, SCHOLTES C, HAÏM-BOUKOBZA S, ROQUE-AFONSO AM, BESSE B, ANDRÉ-GARNIER E, MOHAMED S, HALFON P, PIVERT A, LEGUILLOU-GUILLEMETTE H, ABRAVANEL F, GUIVARCH M, MACKIEWICZ V, LADA O, MOUREZ T, PLANTIER JC, BAAZIA Y, ALAIN S, HANTZ S, THIBAULT V, GAUDY-GRAFFIN C, BOUVET D, MIRAND A, HENQUELL C, GOZLAN J, LAGATHU G, PRONIER C, VELAY A, SCHVOERER E, TRIMOULET P, FLEURY H, BOUVIER-ALIAS M, BROCHOT E, DUVERLIE G, MAYLIN S, GOURIOU S, PAWLOTSKY JM, MORAND P. Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin. J Clin Microbiol. 2015. 53(7):2195-202. doi : 10.1128/JCM.03633-14. PubMed PMID : 25926499 ; PubMed Central PMCID : PMC4473242.

FRANGE P, ASSOUMOU L, DESCAMPS D, CHÉRET A, GOUJARD C, TRAN L, GOUSSET M, AVETTAND-FENOËL V, BOCKET L, FAFI-KREMER S, GUINARD J, MORAND-JOUBERT L, NICOT F, PLANTIER JC, ROGEZ S, WIRDEN M, ROUZIOUX C, MEYER L, CHAIX ML ; FRENCH ANRS CO 6 PRIMO COHORT, THE ANRS 147 OPTIPRIM CLINICAL TRIAL AND THE AC11 RESISTANCE STUDY GROUPS ; FRENCH ANRS CO 6 PRIMO COHORT THE ANRS 147 OPTIPRIM CLINICAL TRIAL AND THE AC11 RESISTANCE STUDY GROUPS. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12 : impact on susceptibility to first-line strategies. J Antimicrob Chemother. 2015. 70(7):2084-9. doi : 10.1093/jac/dkv049. PubMed PMID : 25885327.

FOURATI S, CHARPENTIER C, AMIEL C, MORAND-JOUBERT L, REIGADAS S, TRABAUD MA, DELAUGERRE C, NICOT F, RODALLEC A, MAILLARD A, MIRAND A, JEULIN H, MONTÈS B, BARIN F, BETTINGER D, LE GUILLOU-GUILLEMETTE H, VALLET S, SIGNORI-SCHMUCK A, DESCAMPS D, CALVEZ V, FLANDRE P, MARCELIN AG ; ANRS AC11 RESISTANCE STUDY GROUP. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir : a French national study of raltegravir-experienced HIV-1-infected patients. J Antimicrob Chemother. 2015. 70(5):1507-12. doi : 10.1093/jac/dku535. PubMed PMID : 25558077.

CUZIN L, PUGLIESE P, SAUNÉ K, ALLAVENA C, GHOSN J, COTTALORDA J, RODALLEC A, CHAIX ML, FAFI-KREMER S, SOULIÉ C, OUKA M, CHARPENTIER C, BOCKET L, MIRAND A, GUIGUET M ; DAT’AIDS STUDY GROUP. Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy. AIDS. 2015. 29(13):1665-71. doi:10.1097/QAD.0000000000000723. PubMed PMID : 26372277.

SOULIE C, DESCAMPS D, GRUDÉ M, SCHNEIDER V, TRABAUD MA, MORAND-JOUBERT L, DELAUGERRE C, MONTES B, BARIN F, FERRE V, RAYMOND S, JEULIN H, ALLOUI C, YERLY S, PALLIER C, REIGADAS S, SIGNORI-SCHMUCK A, GUIGON A, FAFI-KREMER S, HAÏM-BOUKOBZA S, MIRAND A, MAILLARD A, VALLET S, ROUSSEL C, ASSOUMOU L, CALVEZ V, FLANDRE P, MARCELIN AG ; ANRS RESISTANCE AC11 GROUP. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma. J Antimicrob Chemother. 2015. 70(2):566-72. doi : 10.1093/jac/dku419. PubMed PMID : 25344810.